{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:10:41Z","timestamp":1791691841195,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41574-022-00762-8","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T18:10:39Z","timestamp":1667239839000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies"],"prefix":"10.1038","volume":"19","author":[{"given":"Jasleen","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1945-1034","authenticated-orcid":false,"given":"Elizabeth R.","family":"Seaquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"International Hypoglycaemia Study Group.","year":"2017","unstructured":"International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 40, 155\u2013157 (2017).","journal-title":"Diabetes Care"},{"key":"762_CR2","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2337\/dc17-1624","volume":"40","author":"G Agiostratidou","year":"2017","unstructured":"Agiostratidou, G. et al. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care 40, 1622\u20131630 (2017).","journal-title":"Diabetes Care"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2337\/dc14-1417","volume":"38","author":"U Pedersen-Bjergaard","year":"2015","unstructured":"Pedersen-Bjergaard, U., Faerch, L., Allingbjerg, M. L., Agesen, R. & Thorsteinsson, B. The influence of new European Union Driver\u2019s License Legislation on reporting of severe hypoglycemia by patients with type 1 diabetes. Diabetes Care 38, 29\u201333 (2015).","journal-title":"Diabetes Care"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1210\/jc.2013-1589","volume":"98","author":"RS Weinstock","year":"2013","unstructured":"Weinstock, R. S. et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry. J. Clin. Endocrinol. Metab. 98, 3411\u20133419 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"H Shamoon","year":"1993","unstructured":"Shamoon, H. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N. Engl. J. Med. 329, 977\u2013986 (1993).","journal-title":"N. Engl. J. Med."},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1210\/jc.2018-00142","volume":"103","author":"MM Henriksen","year":"2018","unstructured":"Henriksen, M. M., Andersen, H. U., Thorsteinsson, B. & Pedersen-Bjergaard, U. Hypoglycemic exposure and risk of asymptomatic hypoglycemia in type 1 diabetes assessed by continuous glucose monitoring. J. Clin. Endocrinol. Metab. 103, 2329\u20132335 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.2337\/dc19-0830","volume":"42","author":"JH Pettus","year":"2019","unstructured":"Pettus, J. H. et al. Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patients with type 1 diabetes: a real-world study. Diabetes Care 42, 2220\u20132227 (2019).","journal-title":"Diabetes Care"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0950-351X(05)80218-6","volume":"7","author":"BM Frier","year":"1993","unstructured":"Frier, B. M. Hypoglycemia in the diabetic adult. Baillieres Clin. Endocrinol. Metab. 7, 757\u2013777 (1993).","journal-title":"Baillieres Clin. Endocrinol. Metab."},{"key":"762_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/dom.12689","volume":"18","author":"K Khunti","year":"2016","unstructured":"Khunti, K. et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes. Metab. 18, 907\u2013915 (2016).","journal-title":"Diabetes Obes. Metab."},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1464-5491.2008.02413.x","volume":"25","author":"J Geddes","year":"2008","unstructured":"Geddes, J., Schopman, J. E., Zammitt, N. N. & Frier, B. M. Prevalence of impaired awareness of hypoglycaemia in adults with type 1 diabetes. Diabet. Med. 25, 501\u2013504 (2008).","journal-title":"Diabet. Med."},{"key":"762_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/dmrr.482","volume":"20","author":"U Pedersen-Bjergaard","year":"2004","unstructured":"Pedersen-Bjergaard, U. et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab. Res. Rev. 20, 479\u2013486 (2004).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2337\/dc08-1722","volume":"32","author":"LA Gonder-Frederick","year":"2009","unstructured":"Gonder-Frederick, L. A. et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care 32, 1001\u20131006 (2009).","journal-title":"Diabetes Care"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.2337\/dc07-0067","volume":"30","author":"K Jauch-Chara","year":"2007","unstructured":"Jauch-Chara, K. et al. Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care 30, 2040\u20132045 (2007).","journal-title":"Diabetes Care"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2337\/dc19-0906","volume":"43","author":"ME Lacy","year":"2020","unstructured":"Lacy, M. E. et al. Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID). Diabetes Care 43, 541\u2013548 (2020).","journal-title":"Diabetes Care"},{"key":"762_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(21)00086-3","volume":"9","author":"AM Jacobson","year":"2021","unstructured":"Jacobson, A. M. et al. Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC study. Lancet Diabetes Endocrinol. 9, 436\u2013445 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"762_CR16","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1056\/NEJMoa066397","volume":"356","author":"AM Jacobson","year":"2007","unstructured":"Jacobson, A. M. et al. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842\u20131852 (2007).","journal-title":"N. Engl. J. Med."},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2337\/diacare.20.8.1293","volume":"20","author":"E George","year":"1997","unstructured":"George, E. et al. Preservation of physiological cell responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 20, 1293\u20131298 (1997).","journal-title":"Diabetes Care"},{"key":"762_CR18","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.2337\/diabetes.54.12.3592","volume":"54","author":"PE Cryer","year":"2005","unstructured":"Cryer, P. E. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54, 3592\u20133601 (2005).","journal-title":"Diabetes"},{"key":"762_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1210\/edrv-12-4-356","volume":"12","author":"JE Gerich","year":"1991","unstructured":"Gerich, J. E., Mokan, M., Veneman, T., Korytkowski, M. & Mitrakou, A. Hypoglycemia unawareness. Endocr. Rev. 12, 356\u2013371 (1991).","journal-title":"Endocr. Rev."},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.diabres.2013.12.005","volume":"103","author":"C Hendrieckx","year":"2014","unstructured":"Hendrieckx, C. et al. Severe hypoglycaemia and its association with psychological well-being in Australian adults with type 1 diabetes attending specialist tertiary clinics. Diabetes Res. Clin. Pract. 103, 430\u2013436 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"762_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2337\/dc13-1154","volume":"37","author":"J Lawton","year":"2014","unstructured":"Lawton, J. et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 37, 109\u2013115 (2014).","journal-title":"Diabetes Care"},{"key":"762_CR22","doi-asserted-by":"publisher","first-page":"bvac107","DOI":"10.1210\/jendso\/bvac107","volume":"6","author":"NT Rubin","year":"2022","unstructured":"Rubin, N. T. et al. Relationship between hypoglycemia awareness status on Clarke\/Gold methods and counterregulatory response to hypoglycemia. J. Endocr. Soc. 6, bvac107 (2022).","journal-title":"J. Endocr. Soc."},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.2337\/dc15-2418","volume":"39","author":"CL Lu","year":"2016","unstructured":"Lu, C. L., Shen, H. N., Hu, S. C., Wang, J. D. & Li, C. Y. A population-based study of all-cause mortality and cardiovascular disease in association with prior history of hypoglycemia among patients with type 1 diabetes. Diabetes Care 39, 1571\u20131578 (2016).","journal-title":"Diabetes Care"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2337\/dc14-0920","volume":"38","author":"K Khunti","year":"2015","unstructured":"Khunti, K. et al. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38, 316\u2013322 (2015).","journal-title":"Diabetes Care"},{"key":"762_CR25","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2337\/dc20-2757","volume":"44","author":"ER Fahrmann","year":"2021","unstructured":"Fahrmann, E. R., Adkins, L. & Driscoll, H. K. Modification of the association between severe hypoglycemia and ischemic heart disease by surrogates of vascular damage severity in type 1 diabetes during approximately 30 years of follow-up in the DCCT\/EDIC study. Diabetes Care 44, 2132\u20132139 (2021).","journal-title":"Diabetes Care"},{"key":"762_CR26","first-page":"A103","volume":"64","author":"NG Joy","year":"2015","unstructured":"Joy, N. G. et al. Acute and chronic effects of atomoxetine on symptom awareness and cognitive function during repeated hypoglycemia in healthy individuals [abstract 396-P]. Diabetes 64, A103 (2015).","journal-title":"Diabetes"},{"key":"762_CR27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2337\/dc10-0013","volume":"33","author":"RJ Wright","year":"2010","unstructured":"Wright, R. J. et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33, 1591\u20131597 (2010).","journal-title":"Diabetes Care"},{"key":"762_CR28","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.2337\/dc11-s220","volume":"34","author":"BM Frier","year":"2011","unstructured":"Frier, B. M., Schernthaner, G. & Heller, S. R. Hypoglycemia and cardiovascular risks. Diabetes Care 34, S132\u2013S137 (2011).","journal-title":"Diabetes Care"},{"key":"762_CR29","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1089\/dia.2012.0031","volume":"14","author":"JK Snell-Bergeon","year":"2012","unstructured":"Snell-Bergeon, J. K. & Wadwa, R. P. Hypoglycemia, diabetes, and cardiovascular disease. Diabetes Technol. Ther. 14, S51\u2013S58 (2012).","journal-title":"Diabetes Technol. Ther."},{"key":"762_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00125-003-1292-4","volume":"47","author":"RT Robinson","year":"2004","unstructured":"Robinson, R. T., Harris, N. D., Ireland, R. H., Macdonald, I. A. & Heller, S. R. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with type 1 diabetes. Diabetologia 47, 312\u2013315 (2004).","journal-title":"Diabetologia"},{"key":"762_CR31","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s00125-004-1552-y","volume":"47","author":"NP Murphy","year":"2004","unstructured":"Murphy, N. P. et al. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia 47, 1940\u20131947 (2004).","journal-title":"Diabetologia"},{"key":"762_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2337\/dc11-1739","volume":"35","author":"G Gruden","year":"2012","unstructured":"Gruden, G. et al. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care 35, 125\u2013127 (2012).","journal-title":"Diabetes Care"},{"key":"762_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4158\/EP09260.CR","volume":"16","author":"RJ Tanenberg","year":"2010","unstructured":"Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the \u201cdead-in-bed\u201d syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr. Pract. 16, 244\u2013248 (2010).","journal-title":"Endocr. Pract."},{"key":"762_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1464-5491.1991.tb01516.x","volume":"8","author":"RB Tattersall","year":"1991","unstructured":"Tattersall, R. B. & Gill, G. V. Unexplained deaths of type 1 diabetic patients. Diabet. Med. 8, 49\u201358 (1991).","journal-title":"Diabet. Med."},{"key":"762_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00125-008-1177-7","volume":"52","author":"GV Gill","year":"2009","unstructured":"Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes \u2013 the \u2018dead in bed\u2019 syndrome revisited. Diabetologia 52, 42\u201345 (2009).","journal-title":"Diabetologia"},{"key":"762_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/dc16-2177","volume":"40","author":"P Novodvorsky","year":"2017","unstructured":"Novodvorsky, P. et al. Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care 40, 655\u2013662 (2017).","journal-title":"Diabetes Care"},{"key":"762_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1464-5491.1999.00076.x","volume":"16","author":"SP Laing","year":"1999","unstructured":"Laing, S. P. et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet. Med. 16, 466\u2013471 (1999).","journal-title":"Diabet. Med."},{"key":"762_CR38","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.2337\/dc22-S006","volume":"45","author":"American Diabetes Association Professional Practice Committee.","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes\u20132022. Diabetes Care 45, S83\u2013S96 (2022).","journal-title":"Diabetes Care"},{"key":"762_CR39","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/dom.14475","volume":"23","author":"TS Bailey","year":"2021","unstructured":"Bailey, T. S. et al. Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: results of a phase 3, randomized, double-blind trial. Diabetes Obes. Metab. 23, 2329\u20132335 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"762_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2337\/dc15-1498","volume":"39","author":"MR Rickels","year":"2016","unstructured":"Rickels, M. R. et al. Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study. Diabetes Care 39, 264\u2013270 (2016).","journal-title":"Diabetes Care"},{"key":"762_CR41","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/dom.13278","volume":"20","author":"ER Seaquist","year":"2018","unstructured":"Seaquist, E. R. et al. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting. Diabetes Obes. Metab. 20, 1316\u20131320 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"762_CR42","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc12-2480","volume":"36","author":"ER Seaquist","year":"2013","unstructured":"Seaquist, E. R. et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384\u20131395 (2013).","journal-title":"Diabetes Care"},{"key":"762_CR43","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.2337\/dc11-1579","volume":"35","author":"D Hopkins","year":"2012","unstructured":"Hopkins, D. et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care 35, 1638\u20131642 (2012).","journal-title":"Diabetes Care"},{"key":"762_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/diacare.24.4.637","volume":"24","author":"DJ Cox","year":"2001","unstructured":"Cox, D. J. et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care 24, 637\u2013642 (2001).","journal-title":"Diabetes Care"},{"key":"762_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1207\/s15327558ijbm1104_4","volume":"11","author":"DJ Cox","year":"2004","unstructured":"Cox, D. J. et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int. J. Behav. Med. 11, 212\u2013218 (2004).","journal-title":"Int. J. Behav. Med."},{"key":"762_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29488-x","volume":"13","author":"SA Amiel","year":"2022","unstructured":"Amiel, S. A. et al. A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc). Nat. Commun. 13, 2229 (2022).","journal-title":"Nat. Commun."},{"key":"762_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck, R. W. et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317, 371\u2013378 (2017).","journal-title":"JAMA"},{"key":"762_CR48","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","volume":"391","author":"L Heinemann","year":"2018","unstructured":"Heinemann, L. et al. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet 391, 1367\u20131377 (2018).","journal-title":"Lancet"},{"key":"762_CR49","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1001\/jama.2020.6940","volume":"323","author":"LM Laffel","year":"2020","unstructured":"Laffel, L. M. et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA 323, 2388\u20132396 (2020).","journal-title":"JAMA"},{"key":"762_CR50","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1001\/jama.2020.6928","volume":"323","author":"RE Pratley","year":"2020","unstructured":"Pratley, R. E. et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. JAMA 323, 2397\u20132406 (2020).","journal-title":"JAMA"},{"key":"762_CR51","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.2337\/dc14-0030","volume":"37","author":"SA Little","year":"2014","unstructured":"Little, S. A. et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 x 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 37, 2114\u20132122 (2014).","journal-title":"Diabetes Care"},{"key":"762_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/diacare.23.5.639","volume":"23","author":"RE Ratner","year":"2000","unstructured":"Ratner, R. E. et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23, 639\u2013643 (2000).","journal-title":"Diabetes Care"},{"key":"762_CR53","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1463-1326.2012.01627.x","volume":"14","author":"T Heise","year":"2012","unstructured":"Heise, T. et al. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes. Metab. 14, 859\u2013864 (2012).","journal-title":"Diabetes Obes. Metab."},{"key":"762_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.2017.7115","volume":"318","author":"W Lane","year":"2017","unstructured":"Lane, W. et al. Effect of insulin degludec vs insulin glargine U100 on hypoglycemia in patients with type 1 diabetes: the SWITCH 1 randomized clinical trial. JAMA 318, 33\u201344 (2017).","journal-title":"JAMA"},{"key":"762_CR55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/dc14-0006","volume":"38","author":"RHA Becker","year":"2015","unstructured":"Becker, R. H. A. et al. New insulin glargine 300 units.mL\u22121 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units.mL\u22121. Diabetes Care 38, 637\u2013643 (2015).","journal-title":"Diabetes Care"},{"key":"762_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/dom.13048","volume":"20","author":"PD Home","year":"2018","unstructured":"Home, P. D. et al. Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U\/mL versus glargine 100 U\/mL in people with type 1 diabetes (EDITION 4). Diabetes Obes. Metab. 20, 121\u2013128 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"762_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/dia.2020.0129","volume":"22","author":"MT Malecki","year":"2020","unstructured":"Malecki, M. T. et al. Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D continuous glucose monitoring substudy. Diabetes Technol. Ther. 22, 853\u2013860 (2020).","journal-title":"Diabetes Technol. Ther."},{"key":"762_CR58","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jama.293.7.830","volume":"293","author":"BJ Hering","year":"2005","unstructured":"Hering, B. J. et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J. Am. Med. Assoc. 293, 830\u2013835 (2005).","journal-title":"J. Am. Med. Assoc."},{"key":"762_CR59","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1210\/jc.2016-1649","volume":"101","author":"MR Rickels","year":"2016","unstructured":"Rickels, M. R. et al. Long-term improvement in glucose control and counterregulation by islet transplantation for type 1 diabetes. J. Clin. Endocrinol. Metab. 101, 4421\u20134430 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"762_CR60","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","volume":"39","author":"BJ Hering","year":"2016","unstructured":"Hering, B. J. et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39, 1230\u20131240 (2016).","journal-title":"Diabetes Care"},{"key":"762_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1303576","volume":"369","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal, R. M. et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N. Engl. J. Med. 369, 224\u2013232 (2013).","journal-title":"N. Engl. J. Med."},{"key":"762_CR62","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2337\/dc18-0771","volume":"41","author":"GP Forlenza","year":"2018","unstructured":"Forlenza, G. P. et al. Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41, 2155\u20132161 (2018).","journal-title":"Diabetes Care"},{"key":"762_CR63","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown, S. A. et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N. Engl. J. Med. 381, 1707\u20131717 (2019).","journal-title":"N. Engl. J. Med."},{"key":"762_CR64","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann, M. et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 392, 1321\u20131329 (2018).","journal-title":"Lancet"},{"key":"762_CR65","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2337\/dc21-0172","volume":"44","author":"SA Brown","year":"2021","unstructured":"Brown, S. A. et al. Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 44, 1630\u20131640 (2021).","journal-title":"Diabetes Care"},{"key":"762_CR66","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2337\/diacare.14.11.949","volume":"14","author":"DA Hepburn","year":"1991","unstructured":"Hepburn, D. A. et al. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach. Diabetes Care 14, 949\u2013957 (1991).","journal-title":"Diabetes Care"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00762-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00762-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00762-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:16:52Z","timestamp":1676384212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-022-00762-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1038\/s41574-022-00762-8","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"30 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}